Health Condition 1: K649- Unspecified hemorrhoids
Conditions
Interventions
None listed
Sponsors
Dabur India Limited
Eligibility
Inclusion criteria
Inclusion criteria: Participants must be willing to commit to medication dosing and assessment visits for evaluation. Participants must be willing to refrain from taking any other medications for treatment of haemorrhoids including painkiller laxatives or stool softener from the outset of the study until final evaluation
Exclusion criteria
Exclusion criteria: Participants who in Investigators opinion will not be able to follow study procedures. Patients currently using other anti-haemorrhoidal drugs or having taken any herbal medications in the last 30 days or planning to undergo any surgical procedure for haemorrhoids will be excluded from the study. Subjects who are pregnant or lactating mothers. Thrombosed & Strangulated pile mass (Haemorrhoids).Known case of Bleeding diathesis, Ulcerative colitis / Crohns disease. Patients with evidence of malignancy. Patient suffering from infective disorders e.g. Hepatitis Tuberculosis, HIV. Patients with significant hepatic renal or cardiovascular ailments will also be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Minimization of fresh bleeding related to defecation. Reduction from the Discomfort (Pain, Itching) in anal region. Change in size of pile mass.Timepoint: End of 1st, 2nd and 3rd week. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in mucus secretion. Relieving in burning sensation in anal region. Cramping around anal region. Healing of crack or tear in skin around anal region.Timepoint: day0 to day 28 | — |
Countries
India
Contacts
Public ContactDr Baidyanath Mishra
Dabur India Limited
Outcome results
None listed